Cargando…

Risk of depressive disorders after tobacco smoking cessation: a retrospective cohort study in Fukuoka, Japan

OBJECTIVE: We sought to examine the effect of smoking cessation on subsequent development of depressive disorders. DESIGN: This was a retrospective cohort study. METHODS: We used administrative claim and health check data from fiscal years 2010 to 2014, obtained from the largest health insurance ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Takako, Babazono, Akira, Harano, Yumi, Jiang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475226/
https://www.ncbi.nlm.nih.gov/pubmed/30904860
http://dx.doi.org/10.1136/bmjopen-2018-025124
_version_ 1783412738918187008
author Fujita, Takako
Babazono, Akira
Harano, Yumi
Jiang, Peng
author_facet Fujita, Takako
Babazono, Akira
Harano, Yumi
Jiang, Peng
author_sort Fujita, Takako
collection PubMed
description OBJECTIVE: We sought to examine the effect of smoking cessation on subsequent development of depressive disorders. DESIGN: This was a retrospective cohort study. METHODS: We used administrative claim and health check data from fiscal years 2010 to 2014, obtained from the largest health insurance association in Fukuoka, Japan. Study participants were between 30 and 69 years old. The end-point outcome was incidence of depressive disorders. Survival analysis and Cox proportional hazards models were conducted. The evaluated potential confounders were sex, age, standard monthly income and psychiatric medical history. RESULTS: The final number of participants was 87 255, with 7841 in the smoking cessation group and 79 414 in the smoking group. The result of survival analysis showed no significant difference in depressive disorders between the two groups. The results of Cox proportional hazards models showed no significant difference by multivariate analysis between participants, including users of smoking cessation medication (HR 1.04, 95% Cl 0.89 to 1.22) and excluding medication use (HR 0.97, 95% Cl 0.82 to 1.15). CONCLUSIONS: The present study showed that there were no significant differences with respect to having depressive disorders between smoking cessation and smoking groups. We also showed that smoking cessation was not related to incidence of depressive disorders among participants, including and excluding users of smoking cessation medication, after adjusting for potential confounders. Although the results have some limitations because of the nature of the study design, our findings will provide helpful information to smokers, health professionals and policy makers for improving smoking cessation.
format Online
Article
Text
id pubmed-6475226
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-64752262019-05-07 Risk of depressive disorders after tobacco smoking cessation: a retrospective cohort study in Fukuoka, Japan Fujita, Takako Babazono, Akira Harano, Yumi Jiang, Peng BMJ Open Public Health OBJECTIVE: We sought to examine the effect of smoking cessation on subsequent development of depressive disorders. DESIGN: This was a retrospective cohort study. METHODS: We used administrative claim and health check data from fiscal years 2010 to 2014, obtained from the largest health insurance association in Fukuoka, Japan. Study participants were between 30 and 69 years old. The end-point outcome was incidence of depressive disorders. Survival analysis and Cox proportional hazards models were conducted. The evaluated potential confounders were sex, age, standard monthly income and psychiatric medical history. RESULTS: The final number of participants was 87 255, with 7841 in the smoking cessation group and 79 414 in the smoking group. The result of survival analysis showed no significant difference in depressive disorders between the two groups. The results of Cox proportional hazards models showed no significant difference by multivariate analysis between participants, including users of smoking cessation medication (HR 1.04, 95% Cl 0.89 to 1.22) and excluding medication use (HR 0.97, 95% Cl 0.82 to 1.15). CONCLUSIONS: The present study showed that there were no significant differences with respect to having depressive disorders between smoking cessation and smoking groups. We also showed that smoking cessation was not related to incidence of depressive disorders among participants, including and excluding users of smoking cessation medication, after adjusting for potential confounders. Although the results have some limitations because of the nature of the study design, our findings will provide helpful information to smokers, health professionals and policy makers for improving smoking cessation. BMJ Publishing Group 2019-03-23 /pmc/articles/PMC6475226/ /pubmed/30904860 http://dx.doi.org/10.1136/bmjopen-2018-025124 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Public Health
Fujita, Takako
Babazono, Akira
Harano, Yumi
Jiang, Peng
Risk of depressive disorders after tobacco smoking cessation: a retrospective cohort study in Fukuoka, Japan
title Risk of depressive disorders after tobacco smoking cessation: a retrospective cohort study in Fukuoka, Japan
title_full Risk of depressive disorders after tobacco smoking cessation: a retrospective cohort study in Fukuoka, Japan
title_fullStr Risk of depressive disorders after tobacco smoking cessation: a retrospective cohort study in Fukuoka, Japan
title_full_unstemmed Risk of depressive disorders after tobacco smoking cessation: a retrospective cohort study in Fukuoka, Japan
title_short Risk of depressive disorders after tobacco smoking cessation: a retrospective cohort study in Fukuoka, Japan
title_sort risk of depressive disorders after tobacco smoking cessation: a retrospective cohort study in fukuoka, japan
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475226/
https://www.ncbi.nlm.nih.gov/pubmed/30904860
http://dx.doi.org/10.1136/bmjopen-2018-025124
work_keys_str_mv AT fujitatakako riskofdepressivedisordersaftertobaccosmokingcessationaretrospectivecohortstudyinfukuokajapan
AT babazonoakira riskofdepressivedisordersaftertobaccosmokingcessationaretrospectivecohortstudyinfukuokajapan
AT haranoyumi riskofdepressivedisordersaftertobaccosmokingcessationaretrospectivecohortstudyinfukuokajapan
AT jiangpeng riskofdepressivedisordersaftertobaccosmokingcessationaretrospectivecohortstudyinfukuokajapan